Dangerous chemicals found in major CBD company’s products
A study conducted by researchers at Virginia Commonwealth University, and published this month in the Forensic Science International, found that several products from Diamond CBD, a publicly traded company, contained a dangerous chemical compound. Found in synthetic marijuana products such as “K2” and “Spice” – which the Drug Enforcement Agency claims can trigger panic attacks, cause convulsions, damage organs and even cause death – the compound 5F-ADB showed up in several Diamond CBD products.
One product tested positive for a cough drug ingredient called dextromethorphan. Teens have been known to abuse dextromethorphan to get high.
The study raises serious questions about Diamond CBD, a company that claims to only sell hemp-derived CBD products. Unlikely marijuana-derived CBD, which contains higher levels of the psychoactive cannabis compound THC, hemp-derived CBD does not contain more than 0.3 percent THC, considered a negligible amount. Users of hemp-derived CBD should be confident that the products they purchase will not cause intoxication.
“The industry is currently self-policing,” said Michelle Peace, Ph.D., assistant professor of forensic science at Virginia Commonwealth University and co-author of the study. “Without federal regulations guiding the oversight and protections of the general public, there is going to be opportunity for abuse that is really going to put public health and public safety at risk.”
Diamond CBD’s CEO denied the accuracy of the tests to Consumer Reports and insisted that the company’s products are put through rigorous third-party testing. He also said that Diamond CBD plans to retest all products and, if necessary, issue recalls.
“The company strives to provide the assurance that we supply the best, highest-quality products on the market,” he added.
Professor Peace acknowledged that the study only looked at a handful of Diamond CBD products, but stood by the published report.